RHEACELL GmbH & Co. KG: From Chronic to Curable? RHEACELL is Developing a Novel Cell-Therapy Agent for the Treatment of Chronic Venous Ulcers
HEIDELBERG, GERMANY / ACCESSWIRE / October 19, 2021 / Heidelberg-based biopharmaceutical company is conducting a follow-up study with highly purified stem cells (AMESANAR (R) ) for the treatment of previously
Source: finanznachrichten.de